Ann: Change of Director's Interest Notice - J Moore, page-28

First 28 Last

Share
Profile

Follow
fitsch

3,147 Posts.

66

02/12/20

20:10

Post #: 49306474
Share

Originally posted by Kalenn: ↑

IMO the only real risk here is the opportunity cost if it takes longer than expected. I do not imagine for one second that the Myanmar government would want to; a) sully their reputation in international investment markets, b) miss out on the cudos of the jobs generated in an high unemployment rural area or miss out for years to come on that important PSA agreement money. The spreadsheets I throw up are also an indication of the enormous sums that will flow to government within 2 to 3 years once MIC license granted.

Yes, technically, there is a risk that something could go seriously wrong but that risk is getting increasingly small and has been approaching zero for the past 3 years. The above are just a few of the risk mitigating factors.

Every event that takes us closer to finalisation of the MIC also takes the risk closer to zero and the reward closer to substantial!

You can remove all risk for yourself by selling, but of course that removes all chance of success as well.

In the meantime, the company states clearly that they expect the invitation to submit the MIC to arrive this month. If they thought differently I believe they would notify the market. I fully expect they will receive the invitation to submit MIC application within weeks. Most likely in December but if not then shortly after.

The company (and who is in a better position to judge this?) has suggested December submission and typically an 8 week process to get through to the awarding of the MIC licence.

Even though I too would like it yesterday, it seems a very modest time to wait.

Expand

Hi Kalenn,
Like you I was a shareholder of AVB for years the share-price of AVB just never really took of, When things starting to come together for AVB it got taken out by OZL for peanuts.
I can,t help but MYL looks more and more like AVB.
It will probably get taken out for peanuts as well,just when things come together.
I hope like hell I am wrong.

I hold a few MYL,rvr and my dark horse is cro.

MYL Price at posting: 7.6¢ Sentiment: Hold Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

RMX

Red Mountain Mining: record gold prices, two projects, two greenstone belts

PRU

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

LAM

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

QML

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

SBW

Shekel Brainweigh investor presentation webinar – the future of retail automation

CBA breaks trading record on strong day for Aussie financials

OCC

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

As Nvidia cools, we're looking to Aussie AI

BIT

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

There are more pages in this discussion • 156 more messages in this thread...

First 28 Last

Add MYL (ASX) to my watchlist

Ann: Change of Director's Interest Notice - J Moore, page-28

Top Stories

Red Mountain Mining: record gold prices, two projects, two greenstone belts

Perseus Mining boosts stake in Predictive Discovery to 19.9% as latter's flagship project stalls

Laramide sniffs prime Kazakh uranium, with agreement over 6000 square km land position

Metallurgical testing shows saleable copper and pyrite from QMines' Develin Creek project

Week 36 Wrap: AI hype wave tested again; Oz per capita recession continues; AirTrunk’s $40B+ payday

Shekel Brainweigh investor presentation webinar – the future of retail automation

CBA breaks trading record on strong day for Aussie financials

Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil

As Nvidia cools, we're looking to Aussie AI

HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo

Featured News